Vis enkel innførsel

dc.contributor.authorPukkila, Jenni
dc.contributor.authorMustaniemi, Sanna
dc.contributor.authorLingaiah, Shilpa
dc.contributor.authorLappalainen, Olli-Pekka
dc.contributor.authorKajantie, Eero Olavi
dc.contributor.authorPouta, Anneli
dc.contributor.authorKaaja, Risto
dc.contributor.authorEriksson, Johan G.
dc.contributor.authorLaivuori, Hannele
dc.contributor.authorGissler, Mika
dc.contributor.authorVääräsmäki, Marja
dc.contributor.authorKeikkala, Elina
dc.date.accessioned2023-01-31T15:49:33Z
dc.date.available2023-01-31T15:49:33Z
dc.date.created2022-09-26T09:44:33Z
dc.date.issued2022
dc.identifier.citationInternational Journal of Environmental Research and Public Health (IJERPH). 2022, 19 (17), .en_US
dc.identifier.issn1661-7827
dc.identifier.urihttps://hdl.handle.net/11250/3047505
dc.description.abstract(1) Hyperglycemia and oral pathology accelerate each other in diabetes. We evaluated whether gestational diabetes mellitus (GDM) is associated with self-reported increased oral health care needs and oral symptoms, including third molar symptoms, during pregnancy. (2) Pregnant women with (n = 1030) and without GDM (n = 935) were recruited in this multicenter Finnish Gestational Diabetes study in 2009–2012. Of the women with GDM, 196 (19.0%) receiving pharmacological treatment, 797 (77.0%) receiving diet treatment and 233 (23.0%) with recurrent GDM were analyzed separately. Oral health was assessed using structured questionnaires and analyzed by multivariable logistic regression adjusted for background risk factors. (3) Women with GDM were more likely to report a higher need for oral care than controls (31.1% vs. 24.5%; odds ratio (OR) 1.39; 95% confidence interval (CI) 1.14–1.69), particularly women with recurrent GDM (38.1% vs. 24.5%; OR 1.90; 95% CI 1.40–2.58). Women with pharmacologically treated GDM (46.9%) more often had third molar symptoms than controls (36.1%; OR 1.57; 95% CI 1.15–2.15) than women with diet-treated GDM (38.0%; OR 1.47; 95% CI 1.07–2.02). (4) GDM is associated with perceived oral care needs. Third molar symptoms were associated with pharmacologically treated GDM.en_US
dc.language.isoengen_US
dc.publisherMDPIen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleIncreased Oral Care Needs and Third Molar Symptoms in Women with Gestational Diabetes Mellitus: A Finnish Gestational Diabetes Case-Control Studyen_US
dc.title.alternativeIncreased Oral Care Needs and Third Molar Symptoms in Women with Gestational Diabetes Mellitus: A Finnish Gestational Diabetes Case-Control Studyen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.source.pagenumber16en_US
dc.source.volume19en_US
dc.source.journalInternational Journal of Environmental Research and Public Health (IJERPH)en_US
dc.source.issue17en_US
dc.identifier.doi10.3390/ijerph191710711
dc.identifier.cristin2055255
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal